Pfizer Building its Distribution Network for Inlyta

Pfizer received approval from the FDA on January 27th for their new drug, Inlyta (axitinib) for the treatment of renal cell carcinoma (kidney cancer).

Inlyta is just 1 of 7 drugs approved for the treatment of metastatic or advanced kidney cancer since 2005. Inlyta is an oral tablet taken twice daily and works by blocking certain proteins called, kinases that play a role in tumor growth and cancer progression (FDA.gov).

Testing of Inlyta was evaluated in an open-label, single randomized, multi-center clinical study of roughly 700 patients whose disease had progressed on or after treatment with one prior systemic therapy.

The study was developed to track the amount of time a patient went without showing signs of cancer progression. The conclusion showed that patients taking the drug lived an average of 2 months longer without sign of cancer progression (from 4.7 months to 6.7 months).

The Apothecary Shops and Biologics, Inc. recently signed agreements with Pfizer to start carrying and dispensing Inlyta, effective immediately.

Since opening its first location in Arizona in 1996, The Apothecary Shops has focused on specific areas of disease states, including oncology, and has extensive experience in providing medications for patients with cancer-related illnesses and diseases.

To best serve their oncology patients, The Apothecary Shops have a dedicated oncology team that includes clinical pharmacists, Patient Care Coordinators, Financial Assistance and Prior Authorizations Specialists, and Regional Oncology Account Managers.

Biologics, Inc. is an integrated oncology services company with an innovative business model that brings together the many complex components of cancer care to provide a patient-focused platform for managing the financial, emotional and physical burdens of cancer treatment.

Biologics is at the center of the rapidly changing oncology environment to support treatment modalities, clinical outcomes and informatics and leverage established relationships with oncology clinicians, patients, payors, researchers and manufacturers. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Biologics, Inc. is headquartered in Cary, N.C.

Additional information available